These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 923806)

  • 41. Vasopressin and oxytocin production by non-neuroendocrine lung carcinomas: an apparent low incidence of gene expression.
    Friedmann AS; Memoli VA; North WG
    Cancer Lett; 1993 Dec; 75(2):79-85. PubMed ID: 8293425
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurohypophysial peptides. Design of tissue-specific agonists and antagonists.
    Sawyer WH; Grzonka Z; Manning M
    Mol Cell Endocrinol; 1981 May; 22(2):117-34. PubMed ID: 6263733
    [No Abstract]   [Full Text] [Related]  

  • 43. Kinetics of precursor cleavage at the dibasic sites. Involvement of peptide dynamics.
    Glandieres JM; Hertzog M; Lazar N; Brakch N; Cohen P; Alpert B; Rholam M
    FEBS Lett; 2002 Apr; 516(1-3):75-9. PubMed ID: 11959107
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biosynthesis of vasopressin and oxytocin.
    Brownstein MJ
    Annu Rev Physiol; 1983; 45():129-35. PubMed ID: 6847162
    [No Abstract]   [Full Text] [Related]  

  • 45. In vivo apparent peptide-receptor dissociation rate constants for arginine vasopressin analogs estimated from inhibition of rat pressor responses.
    Gazis D
    Can J Physiol Pharmacol; 1987 Oct; 65(10):2099-103. PubMed ID: 2827873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Arginine-vasotocin, a synthetic analogue of the posterior pituitary hormones containing the ring of oxytocin and the side chain of vasopressin.
    KATSOYANNIS PG; DU VIGNEAUD V
    J Biol Chem; 1958 Dec; 233(6):1352-4. PubMed ID: 13610841
    [No Abstract]   [Full Text] [Related]  

  • 47. Conformational studies of oxytocin, lysine vasopressin, arginine vasopressin, and arginine vasotocin by carbon-13 nuclear magnetic resonance spectroscopy.
    Walter R; Prasad KU; Deslauriers R; Smith IC
    Proc Natl Acad Sci U S A; 1973 Jul; 70(7):2086-90. PubMed ID: 4516207
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recognition properties of antisense peptides to Arg8-vasopressin/bovine neurophysin II biosynthetic precursor sequences.
    Fassina G; Zamai M; Brigham-Burke M; Chaiken IM
    Biochemistry; 1989 Oct; 28(22):8811-8. PubMed ID: 2605222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vasopressin reduces release from vasopressin-neurons and oxytocin-neurons by acting on V2-like receptors.
    Cheng SW; North WG
    Brain Res; 1989 Feb; 479(1):35-9. PubMed ID: 2522339
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Equilibrium dialysis studies of hormone-neurophysin binding.
    Hruby VJ; Spatola AF; Glasel JA; McKelvy JF
    Ann N Y Acad Sci; 1975 Feb; 248():451-7. PubMed ID: 235234
    [No Abstract]   [Full Text] [Related]  

  • 51. Intra-axonal transport and turnover of neurophysins in the rat. A proposal for a possible origin of the minor neurophysin component.
    Burford GD; Pickering BT
    Biochem J; 1973 Dec; 136(4):1047-52. PubMed ID: 4786526
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contribution of the peptide backbone to the binding of peptides and hormones to neurophysin.
    Carlson J; Breslow E
    Biochem Biophys Res Commun; 1981 May; 100(1):455-62. PubMed ID: 7259761
    [No Abstract]   [Full Text] [Related]  

  • 53. Hormonal interactions at the molecular level. A study of oxytocin and vasopressin binding to bovine neurophysins.
    Camier M; Alazard R; Cohen P
    Eur J Biochem; 1973 Jan; 32(2):207-14. PubMed ID: 4734532
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunocytochemical evidence for somatic repair of the mutant AVP allele in heterozygous Brattleboro rats.
    Pow DV; Morris JF
    Ann N Y Acad Sci; 1993 Jul; 689():559-63. PubMed ID: 8373047
    [No Abstract]   [Full Text] [Related]  

  • 55. Putative new regulatory peptides in mammals: phenypressin (Phe2-Arg8-vasopressin) and mesotocin (Ile8-oxytocin).
    Acher R; Chauvet J; Chauvet MT; Hurpet D
    Adv Biochem Psychopharmacol; 1982; 33():533-9. PubMed ID: 6289632
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunohistochemical analysis of magnocellular elements in rat hypothalamus: distribution and numbers of cells containing neurophysin, oxytocin, and vasopressin.
    Rhodes CH; Morrell JI; Pfaff DW
    J Comp Neurol; 1981 May; 198(1):45-64. PubMed ID: 7014660
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction of bovine neurophysin with oxytocin and vasopressin measured by temperature-jump relaxation.
    Pearlmutter AF; McMains C
    Biochemistry; 1977 Feb; 16(4):628-33. PubMed ID: 836804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neurohypophyseal peptide levels in CSF and plasma during passive avoidance behavior in rats.
    Mens WB; van Egmond MA; de Rotte AA; van Wimersma Greidanus TB
    Horm Behav; 1982 Dec; 16(4):371-82. PubMed ID: 7160838
    [No Abstract]   [Full Text] [Related]  

  • 59. Characterization of oxytocin, vasopressin, and neurophysin from the bovine corpus luteum.
    Wathes DC; Swann RW; Birkett SD; Porter DG; Pickering BT
    Endocrinology; 1983 Aug; 113(2):693-8. PubMed ID: 6872945
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interactions of Sepharose-bound neurophysin I and II with oxytocin and vasopressin.
    Fukuda H; Hayakawa T; Kawamura J
    Chem Pharm Bull (Tokyo); 1980 Nov; 28(11):3418-22. PubMed ID: 7214614
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.